PRGO Q3 2019 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

Q3 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.2B+5.1% YoY

Gross Profit

$413M34.7% margin

Operating Income

$54M4.6% margin

Net Income

$92M7.7% margin

EPS (Diluted)

$0.67

QoQ Revenue Growth

+3.7%

Cash Flow

Operating Cash Flow

$140M

Free Cash Flow

$104M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$11.3B

Total Liabilities

$5.6B

Stockholders' Equity

$5.8B

Cash & Equivalents

$399M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$1.1B	+5.1%
Gross Profit	$413M	$425M	-2.8%
Operating Income	$54M	-$122M	+144.6%
Net Income	$92M	-$68M	+236.6%

Revenue Segments

Consumer Self-Care Americas

$613M51%

Consumer Self-Care International

$348M29%

RX Pharmaceuticals

$230M19%

Geographic Segments

UNITED STATES

$786M66%

Europe

$335M28%

Other Geographical Areas

$71M6%

IRELAND

$5M0%